Desk›Healthcare› Natural Capsules Ltd
Natural Capsules Ltd
BSE 524654 · NSE NATCAPSUQ · ISIN INE936B01015 · Group B · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹214.60
+18.47%
BSE close, 28 August 2026
₹223.42 cr
1.0 cr shares · Micro cap
₹106.44 cr
as published
17.6× · 1.36×
EPS ₹12.22 · BV ₹157.79
173.77 / 11.21
₹ cr, as filed
23
4 selected · 17%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -27.6% |
|---|---|
| Against 52-week low | +56.1% |
| Day change | +18.47% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹12.22 |
|---|---|
| Price / earnings | 17.56× |
| Price / book | 1.36× |
| Book value — derived, price ÷ P/B | ₹157.79 |
| Return on equity | 7.77% |
| Operating margin | 21.39% |
| Net margin | 9.38% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 7.74%
- ROE as published
- 7.77%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 43.02 | 4.04 | 3.89 | 21.39% | 9.38% |
| Mar-26 · Q | 50.80 | 5.52 | 5.33 | 21.62% | 10.86% |
| FY25-26 | 173.77 | 11.21 | 10.79 | 16.68% | 6.45% |
Quarter on quarter
- Revenue, quarter on quarter
- -15.3%
- Net profit, quarter on quarter
- -26.8%
- Operating margin, quarter on quarter
- -23 bps
Disclosure profile 23 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 2 |
| Investor Presentation | 1 |
| Press Release | 1 |
| Selected sub-total | 4 |
| Procedural | |
| AGM / EGM | 5 |
| General | 4 |
| Newspaper Publication | 4 |
| Board Meeting | 2 |
| Compliance Certificate | 1 |
| Meeting Update | 1 |
| Record Date | 1 |
| Trading Window | 1 |
| Procedural sub-total | 19 |
| Total | 23 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
23 filings · 4 selected · busiest 2026-08-12 and 2026-08-13
Filing rhythm · the twelve most recent
2026-08-182026-10-09
SelectedProcedural
Filings
23 in the window · 10 earlier on record
-
9 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we hereby submit the certificate received from Cameo Corporate Services Limited, Registrar & ....
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
25 September 2026 ·
Closure of Trading Window
We wish to inform that the "Trading Window" for dealing in the equity shares of the company shall remain closed for all Designated Person and their immediate relatives with effect from ....
Insider Trading / SAST / Closure of Trading Window View filing →
-
9 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Pursuant to Reg 44(3) of SEBI (LODR) Regulations, 2025 , We are Submitting herewith voting results of 1st Extra-Ordinary General Meeting 2026 of the company held on Wednesday, September 2026
AGM/EGM / EGM View filing →
-
9 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of EGM
Pursuant to Regulations 30 of SEBI (LODR) Regulation, 2015 please find the enclosed proceedings of the of 1st Extraordinary General Meeting 2026 of the Company held on Wednesday September ....
AGM/EGM / EGM View filing →
-
3 September 2026 ·
Newspaper Publication
Newspaper Publication for Completion of dispatch of Corrigendum Notice of Extraordinary General Meeting ("EGM").
Company Update / Newspaper Publication View filing →
-
2 September 2026 ·
Meeting Updates
We wish to inform you that the company has today, Wednesday, September 02, 2026, completed the dispatch of the Corrigendum to the EGM Notice to all eligible members of the Company.
Company Update / Meeting Updates View filing →
-
2 September 2026 ·
Board Meeting Outcome for Outcome Of The Board Meeting Held On Wednesday September 02, 2026 At Shorter Notice
1. Approved the Revised Price and Quantity of Equity Shares and Convertible Warrants of Preferential Issue. 2. Approval of the Corrigendum Notice of Extra Ordinary General Meeting.
Board Meeting / Outcome of Board Meeting View filing →
-
1 September 2026 ·
524654 - Board Meeting Intimation for Intimation Under Regulation 29 And Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Board Meeting Scheduled At Shorter Notice On September 02, 2026
Natural Capsules Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
Board Meeting / Board Meeting View filing →
-
19 August 2026 ·
Newspaper Publication
Copy of Newspaper Publication (i.e., Dispatch of EGM Notice for the attention of the Equity shareholders)
Company Update / Newspaper Publication View filing →
-
18 August 2026 ·
Newspaper Publication
Copy of Newspaper Advertisement, i.e Notice for attention of equity shareholders of the company.
Company Update / Newspaper Publication View filing →
-
18 August 2026 ·
Intimation Of Record Date For Extraordinary General Meeting ('EGM') Is Fixed On September 2Nd, 2026.
Cut-off Date (Record Date) for Extraordinary General Meeting ("EGM") is fixed on September 2nd, 2026.
Corp. Action / Record Date View filing →
-
18 August 2026 ·
Notice Of The Extraordinary General Meeting (EGM) Of The Company Scheduled To Be Held On Wednesday September 09, 2026 At 12:00 PM (IST)
We are hereby submitting the Notice of the Extraordinary General Meeting (EGM) of the Company scheduled to be held on Wednesday, September 09, 2026 at 12:00 PM (IST) through Video Conference ....
AGM/EGM / EGM View filing →
-
17 August 2026 ·
Intimation Under Regulation 30(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Resignation Of Independent Director Of Material Unlisted Subsidiary.
This is to inform you that Mr. Pramod Kasat has tendered his resignation from the position of Independent Director of Natural Biogenex Private Limited ("Material Unlisted Subsidiary"), ....
Company Update / General View filing →
-
14 August 2026 ·
Newspaper Publication
We hereby inform that the Unaudited Financial Results for the Quarter ended June 30, 2026, has been published in Business Line, an English Daily & Sanjevani a Kannada daily.
Company Update / Newspaper Publication View filing →
-
13 August 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
We are submitting herewith voting results & scrutinizers report of 33rd AGM of Natural Capsules Limited.
AGM/EGM / AGM View filing →
-
13 August 2026 ·
Investor Presentation
Please find enclosed herewith the copy of Investors Presentation in connection with the Unaudited Consolidated & Standalone Financial Results for quarter ended June 30, 2026.
Company Update / Investor Presentation View filing →
-
13 August 2026 ·
Press Release / Media Release
Please find enclosed herewith the copy of Press Release made to analysts and investors in connection with the Unaudited Consolidated & Standalone Financial Results for quarter ended June 30, 2026.
Company Update / Press Release / Media Release View filing →
-
12 August 2026 ·
524654 - Intimation Under Regulation 30(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Natural Biogenex Private Limited ("Material Unlisted Subsidiary"), at its Board Meeting held on today has appointed Mr. K. H. Honneshaiah as the new Chief Operating Officer of the Company.
Company Update / General View filing →
-
12 August 2026 ·
Board Meeting Outcome for Outcome Of The Board Meeting Held On Wednesday August 12, 2026
1. Approved the unaudited Consolidated & Standalone Financial Results of the Company for the Quarter ended June 30, 2026. 2. Preferential Issue of Equity Shares and Warrants to Promoter.
Board Meeting / Outcome of Board Meeting View filing →
-
12 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
33rd Annual General Meeting of the Company held on Wednesday August 12, 2026 at 12.10 P.M. through Video conferencing ("VC") other Audio-visual Means ("OAVM") and was concluded at 01:00 PM.
AGM/EGM / AGM View filing →
-
4 August 2026 ·
Board Meeting Intimation for Consider And Approve The Unaudited Consolidated & Standalone Financial Results Of The Company For The Quarter Ended June 30Th, 2026.
Natural Capsules Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve 1. To Consider and approve ....
Board Meeting / Board Meeting View filing →
-
31 July 2026 ·
Intimation Under Regulation 30(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Natural Biogenex Private Limited ("Material Unlisted Subsidiary"), at its Board Meeting held on today, i.e. July 31, 2026, has approved the Allotment of the Right Issue duly approved on ....
Company Update / General View filing →
-
29 July 2026 ·
524654 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Dilution Of Equity Shareholding In Subsidiary Company Due To Non-Participation In Rights Issue.
Board of Director of the Company has inter-alia considered and approved a Resolution Passed by Circulation on 28th July, 2026 and the final majority vote was received by 08:00 PM decided ....
Company Update / General View filing →
RSS feed for Natural Capsules Ltd · the 50 most recent filings